Demonstrate the activity of mitomycin C and cisplatin in a patient harboring a PALB2 mutation. Demonstrate that stromal modulation may increase intra-tumor gemcitabine concentrations to improve therapy efficacy. The gene discussed is PALB2; the disease is neoplasm.